Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
$2.02
-4.27%today
MKT CAP
$158M
-26.0% · 1Y
Full Financials
Trailing P/E-
Forward P/E-
EV/EBITDA-91.7x
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin0.0%
Operating Margin0.0%
Net Margin0.0%
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership62.2%
Institutional Ownership0.9%
Short % of Float0.32%
Days to Cover0.8d
1 Week-7.8%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Blackrock Inc. | institution | 0.34% | $0.00B | +100.00% | 2025-12-31 |
| iShares Trust-iShares Biotechnology ETF | fund | 0.27% | $0.00B | -4.18% | 2026-03-31 |
| Jane Street Group, LLC | institution | 0.09% | $0.00B | +100.00% | 2025-12-31 |
| Geode Capital Management, LLC | institution | 0.08% | $0.00B | +19.57% | 2025-12-31 |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | fund | 0.06% | $0.00B | +0.00% | 2026-02-28 |
| Millennium Management Llc | institution | 0.05% | $0.00B | +209.37% | 2025-12-31 |
| UBS Group AG | institution | 0.05% | $0.00B | -74.35% | 2026-03-31 |
| Morgan Stanley | institution | 0.04% | $0.00B | +879.21% | 2025-12-31 |
| Bank of America Corporation | institution | 0.03% | $0.00B | +100.00% | 2025-12-31 |
| Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index ETF | fund | 0.03% | $0.00B | +45.56% | 2026-04-30 |
| Man Group PLC | institution | 0.02% | $0.00B | +100.00% | 2025-12-31 |
| China Universal Asset Management Co., Ltd. | institution | 0.02% | $0.00B | +6.33% | 2026-03-31 |
| Citigroup Inc. | institution | 0.01% | $0.00B | +100.00% | 2025-12-31 |
| Invesco Exchange-Traded Fund Trust II-Invesco Nasdaq Biotechnology ETF | fund | 0.01% | $0.00B | -10.12% | 2026-04-30 |
| ProShares Trust-ProShares Ultra Nasdaq Biotechnology | fund | 0.00% | $0.00B | -9.04% | 2026-04-30 |
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for MENS.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.